Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Vitara RX

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Vitara RX head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 78 · Grade C

Vitara RX

Visit Vitara RX Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 77 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Vitara RX a bad call — it's best for readers who value named care and pharmacy partners and can confirm the selected offer and refill process before enrollment. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
78
Supply Reliability
95
71
Transparency
90
88
Access Breadth
93
84
Clinical Oversight
92
69
Track Record
88
67
CoreAge RxBrief Score 94 · 77Vitara RX

Price, coverage & the tracker

CoreAge RxVitara RX
Brief Score94/100 (A)77/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm selected plan price

Medication headline from $99/mo differs from a $179.99 general-program headline; full terms need confirmation.

Full price details

Current medication quote unknown; earlier observed $99/month for semaglutide

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm selected plan price

Medication headline from $149/mo differs from a $179.99 general-program headline; full terms need confirmation.

Full price details

Current medication quote unknown; earlier observed $149/month for tirzepatide

CoverageUS only; restrictions by state, confirmed at intakeMedication-specific state availability requires confirmation; FAQ describes service in multiple states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Vitara RX: Current complete medication quotes are unconfirmed. The $99 and $149 starting headlines appear alongside a $179.99 general program offer; confirm the applicable plan and renewal bill.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.